A Phase 3b Randomized, Double-blind, Multi-center Study to Compare the Safety and Efficacy of Omadacycline to Moxifloxacin for Treating Adult Subjects With CABP
Conditions: Community-acquired Bacterial Pneumonia Interventions: Drug: Omadacycline; Drug: Moxifloxacin Sponsors: Zai Lab (Hong Kong), Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Avelox | Bacterial Pneumonia | Hong Kong Health | Moxifloxacin | Pneumonia | Research | Study